Matches in Nanopublications for { ?s ?p "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP356838.RAiN4ZcygSWPWZZTSfAACH93ZEJO4NuqGEyQC_MkyLAPk130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356838.RAiN4ZcygSWPWZZTSfAACH93ZEJO4NuqGEyQC_MkyLAPk130_provenance.
- assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.
- NP1311088.RA3qP4pZXbtAaL09N5kRa_sawRZNBgaPaQ3AJEzyKcFq4130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311088.RA3qP4pZXbtAaL09N5kRa_sawRZNBgaPaQ3AJEzyKcFq4130_provenance.